All stock reports

BAYERCROP evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-31T14:00:54.840207+00:00

Metrics

latest_annual_period
2026-03-31
revenue
56750000000.0
net_income
6892000000.0
operating_cash_flow
10968000000.0
free_cash_flow
10569000000.0
total_assets
56994000000.0
total_liabilities
27337000000.0
total_equity
29657000000.0
cash
14792000000.0
total_debt
818000000.0
revenue_growth
0.03683268169693421
earnings_growth
0.2133802816901409
net_margin
0.12144493392070485
roe
0.2323903294331861
debt_to_equity
0.027582021108001484
cash_conversion
1.59141033081834
free_cash_flow_margin
0.18623788546255507
trailing_pe
25.519
forward_pe
17.331
peg_ratio
Not supplied
price_to_book
6.3301
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-369eb5fb1fbcf40e1a411b22139b06e6f846d51685b3db6eb4458fff55fedbed
Policy
stock-decisions-v1
Evidence bundle hash
59d6b968b006343c85b5836be818e7c5900e46bfbe1f66438f30e78e7d0ed40d
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 21f9639c895cf48dbbf1811298cf008eb838fc415c633bb193d529ab398f8c1f
  • daily-price: 53fc9118ab159a9a49a308fc5ee4a6553b09cac6c7ebda4c12dbcfcbca002c25
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.03683268169693421. The cached financial metric net margin is 0.12144493392070485. The cached financial metric roe is 0.2323903294331861. The cached financial metric debt to equity is 0.027582021108001484. The cached financial metric cash conversion is 1.59141033081834.

Risks

The trailing 250-session price return was -26.23%. The closing price was -28.08% below its highest close in the available trailing year. The trailing 60-session price return was -13.44%. The trailing 20-session price return was -10.69%. The trailing 5-session price return was -4.87%. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Price source verification: REPAIRED. Average cached traded value over twenty sessions was INR 128,980,815. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-08-31T14:00:54.840207+00:00 from EODHD.

Cached observations and evidence limits